Ruti Aga Gets Six-Year Ban: A Forged Prescription Turned a Two-Year Doping Case Into the End of a Career

Ethiopian marathon runner Ruti Aga has been banned for six years by the Athletics Integrity Unit (AIU). The sanction, confirmed in an AIU statement issued on Thursday, is not the product of a single violation but of two stacked together. The first is the presence of methylprednisolone — a prohibited substance — in a sample collected at a half marathon in China in March, for which a two-year period was imposed. The second, and the decisive turn in the case, is the submission of a prescription to justify that medication which no real doctor ever wrote and which was issued under the name of a clinic that did not exist. In the language of the rules this second violation is called tampering, and it added four years. Two plus four equals six. The ban is dated from 10 September, the same date on which Aga went on provisional suspension. Under the rules, provisional suspension time is credited against the final sanction, so backdating is standard procedure rather than a concession. The real term is six years, and on any reasonable calculation Aga will be around 38 years old before she is eligible to race again. What makes this case notable is not performance data. The article on which this report is based supplies no mark, no split and no field strength for the Chinese half marathon where the sample was collected. The only performance-relevant fact available is that she won the race, which implies an elite field with in-competition testing in place. Any claim about the standard of the run itself would be speculation. The substance: a glucocorticoid, not an anabolic steroid A technical correction is necessary, because a large part of the reporting has repeated the error. Methylprednisolone is being described as a 'prohibited steroid'. It is not. It is a glucocorticoid, listed under class S9 of the WADA Prohibited List. Anabolic agents sit in class S1. The distinction is not semantic — it changes the legal architecture of the entire case. Under the current List, S9 glucocorticoids are prohibited in-competition only, and only when administered by injection, orally or rectally. A therapeutic knee injection given out of competition is entirely lawful. It becomes a violation only if residues are still present in a sample taken during the competition period. In road running, the testing window opens at 23:59 the day before the race, which means an injection administered days earlier can still be caught if the washout period was not observed. It also matters what the drug actually does. Methylprednisolone suppresses inflammation and pain. It does not build muscle and it does not increase endurance. There is no established performance-enhancing benefit for endurance athletes. It is used for knee synovitis, tendon inflammation and pain management. That is precisely why Aga had a legitimate defence available: real medical records, a documented injection date and route, and correct washout timing would very likely have meant no case at all. She chose the path that destroyed every defence. The forged prescription chain According to the AIU statement, Aga submitted a prescription in her defence. The investigation established that the prescription carried the name of a clinic that did not exist. The person who wrote it was not a registered medical practitioner. That person was a family member. Questioned about the document, the individual claimed to have used 'an old prescription pad from a former workplace'. The clinic named on the pad explicitly disowned it. That is three independent verification failures in sequence. The clinic did not exist. The author held no medical registration. The institution named on the document rejected it. If any one of those layers had held up, the four-year tampering sanction would not exist. It is also worth noting that the tampering charge did not rest on the document alone. According to the AIU, it was also connected to statements made during the investigative interview. This was not purely a paperwork problem; information given under questioning was found to be misleading. Language and interpretation conditions in AIU interviews with Ethiopian athletes have been a recurring point of contention, and this case reopens that debate — though here the documentary evidence is strong enough that the language argument carries limited weight. The arithmetic of the sanction Look at how the six years is built. Two years for the presence violation is consistent with a finding involving a Specified Substance where intent was not established. Four years for tampering is the standard sanction under the Code. Six in total. One important inference follows. Had the panel found a basis to conclude there was no significant fault on the athlete's part, the presence sanction could have been reduced below two years — in some circumstances to a reprimand. That did not happen. Equally, the panel treated the tampering as fully culpable and granted no reduction there either. There is an apparent paradox here. Fabricating a document is itself circumstantial evidence of an intent to conceal, and ordinary reasoning would suggest it should also aggravate the substance violation. It did not. The presence component stayed at two years and four years were added separately for tampering. The outcome is the same, but the legal route is different. Career accounting: Tokyo 2026 and three Major podiums Aga's reputation was not built on this case. She won the 2026 Tokyo Marathon, a World Marathon Major. She also has three second-place finishes at World Marathon Majors, including Berlin 2026, where her time is widely cited at around 2:18:34. Those figures do not come from the primary source in this report and should be treated with appropriate caution, but if accurate they establish that this was not a marginal athlete. Running between 2:18 and 2:20 is world class. There is a legal point that matters here. The violation is anchored to the March race. The source does not state that any earlier result has been annulled. The general principle is that results before the date of the violation are not automatically voided absent evidence of earlier use. Her 2026 Tokyo title therefore remains part of her record. Her result and prize money from the March race, however, are very likely to have been annulled, since standard AIU practice voids the competition at which the sample was collected. The source does not say so explicitly, so this remains an inference. The knee injury: the actual root cause The least discussed part of the case is Aga's explanation that the medication was for a knee injury. Mechanistically, that is entirely plausible. Intra-articular or peri-articular methylprednisolone for knee synovitis is standard sports medicine practice in distance runners. So where is the problem? The problem is that this plausibility is exactly what makes the forgery so damaging. If a genuine, medically appropriate treatment had taken place, real records would have existed and could have been produced. Instead a document was fabricated. That gap is what demonstrates the problem was not the drug but the system around the athlete. Knee pathology is the most common professional risk in marathon running. A body covering 160 to 200 kilometres a week loads the joints continuously. When injury strikes, an athlete has three options: rest, which means losing income; better medical support, which requires resources and institutional structure; or masking the pain and continuing to race. The third option is the cheapest and the easiest. Glucocorticoids are the tool for that third option. There is a further layer. The prescription was written by a family member, which points to an absence of a credentialed team physician. Nobody in the athlete's circle appears to have been in a position to explain what the Prohibited List says, what the washout requirements are, or how to apply for a Therapeutic Use Exemption. A properly managed athlete either holds a TUE or observes the route-specific washout period. Neither happened here, and when questions were asked a document was manufactured. This is not an individual lapse; it is a symptom of a governance gap. The wider East African road-racing context This case is not isolated. AIU cases involving East African road racing show a recognisable pattern: a substance violation is detected, a fabricated or altered explanation is then produced, and the sanction more than doubles. The enforcement frontier has shifted from detection to document verification. The agency is now examining whether the paper submitted in a defence is genuine. There is a structural reason. In these environments, training clusters, agents and informal medical networks overlap. The same clinic, the same 'doctor' and the same type of document can serve multiple athletes. When one case surfaces, the likelihood that similar cases are in the pipeline rises accordingly. That is an inference rather than a proven fact, but it is an inference grounded in case clustering. Impact on the sport: close to zero Competitively, Aga's removal does not measurably weaken Ethiopian women's marathon running. Domestic depth is such that a 2:18 performer cannot assume national selection. World-record class performances are being produced at the top of the event. The departure of a 32-year-old with no global championship medals changes nothing in the selection calculus. Her three Major second places were commercial-tier results, not championship conversions. Set against Kenya, the picture is this: both nations have extreme depth, both have strong half marathon feeder tiers, and both are structurally exposed to this kind of governance failure. Ethiopia currently holds the top end of the event; Kenya holds championship-race conversion. The shared risk is the informal medical apparatus surrounding athletes. China's label-race circuit: where money and testing collide The race at which the sample was collected was a half marathon in China. Its exact tier is not stated, but the reasonable inference is an international-standard road race with an elite women's field and a testing programme, since otherwise no AIU test would exist. The economics of that tier matter. Between Majors, Asian label races are an attractive, low-risk income stream for East African marathoners. Appearance fees are good, the competitive standard is below Major level, and race counts can be kept low. Aga's post-2026 pattern appears consistent with that model: selective Majors plus appearances at Asian label races. But that same tier is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same races, and results at this level will carry increasing integrity risk. The rules framework and prospects of appeal The case was brought under the World Athletics Anti-Doping Rules, enforced by the AIU, applying the WADA Code and Prohibited List. Three categories are relevant. First, in-competition presence of an S9 glucocorticoid. Second, tampering. Third, an aspect not formally part of this proceeding but impossible to ignore: the criminal dimension of document forgery, which sits outside AIU jurisdiction but could be referred to national authorities. The source does not indicate any such referral, so it should be treated as a possibility only. An appeal route exists. A CAS appeal is typically available within about 21 days of the reasoned decision. Success looks unlikely here, because the tampering finding is document-based rather than testimony-based. When the clinic does not exist, the author is unregistered, and the institution disowns the document, the room to overturn the finding is very narrow. Proportionality: the bigger question This is where the case moves beyond a single news item. A six-year ban for a glucocorticoid — a substance with no established endurance benefit — is a striking outcome. It will be read two ways. On one reading it demonstrates AIU rigour and zero tolerance for documentary fraud. The message is clear: submit false documents and the sanction will be driven by the lie, not by the substance. On another reading it will be cited as evidence of disproportionate enforcement against African road runners. There is a grain of truth in both readings. One thing should be stated plainly. Had Aga not produced a forged document, this case would probably have resolved at two years or less. A competent defence could have argued that the knee treatment occurred out of competition and that washout was miscalculated. Reductions in such cases exist. She abandoned that route. The severity of the sanction is therefore primarily the product of her own decision, not of rule rigidity. It is also worth noting that the structure of the sanction is standard, not exceptional. Two years for presence, four for tampering is ordinary arithmetic under the Code. What is exceptional is that the two combined, and that at 32 the combination amounts to career termination. What remains open Several things are unstated and they matter. Were the March result and prize money annulled? What happened to ranking points accrued after that date? Was the role of the agent or management investigated, or was only the family member named? Will there be any national-level action on the document forgery? Did the Ethiopian federation issue any statement? None of these questions is answered in the AIU statement. What is clear is that the competitive landscape of Ethiopian women's marathon running will not shift. The depth is too great for one name to be visible in its absence. The real question is whether this case creates pressure on the mechanism that made it possible: the informal, unregistered, paper-based medical structure around athletes. What happened, in the end, is this: a 32-year-old who won Tokyo in 2026 and finished second at three Majors will be out of the sport until she is 38. In Ethiopia's current depth, a 38-year-old with a doping record is effectively unselectable. The six-year ban is a formal sanction that functions as a lifetime one. And the cause was not the substance. The substance was half the case. The other half was a document written by someone with no medical registration, under the name of a clinic that did not exist, on a pad that the institution in question refused to recognise. That is the real lesson: in the modern anti-doping system a technical error can sometimes be forgiven. A lie cannot.